Biochemical and Structural Investigations on Kynurenine Aminotransferase II: An Example of Conformation-Driven Species-Specific Inhibition?
Keywords: 3OH-KYN; 7 nicotinic receptor; Arg399; Asp230; Bradford assay; DNA sequencing; ESRF; IC50 value; KAT II; Kynurenic acid; L-KYN; L-tryptophan; MOSFLM; N-terminal; NMDA receptor; Neurochemistry studies; PCR-based; PLP-KYN; PLP-enzymes; PMP; Protein aliquots; QUIN; S-ESBA; SCALA; Tyr233; Tyr74; UV/HPLC; X-ray; albumine; catalysis; co-crystallization; cognition enhancing drugs; conformational flexibility; crystal structure; dopamine; drug design; drug selectivity; enzymes; hKAT II; homogeneity; isozymes; ketoacid; ketoglutarate; kinetics; kynurenine aminotransferase II; kynurenines; ligand; mAAT; mammals; mutant; neuroactive; oligomeric; schizophrenia; stabilization; wild-type
Document Type: Research Article
Publication date: 01 January 2011
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content